NEOG

Neogen Corporation

$11.67

-3.39%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns.

Source: Yahoo Finance
AI summary

Price & performance

1M-2.7%
3M-1.8%
YTD+68.9%
1Y+91.6%
52-week range—
Beta0.65
Full chart and returns against a benchmark

Q-Score

51/ 100

Quality against peers; 50 is the peer median.

Growth45
Risk58
Performance46
Valuation57
Profitability56
Leverage48
Sentiment55
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$870.4M-2.7%
Net income-$7.9M
Net margin-0.9%+121.1 pts
Historical fundamentals

Revenue exposure

51%of revenue from outside the US
Non Us51%
United States49%
Largest customer10%
Regions, segments, customers and suppliers

Valuation

NEOGIndustryP/E—29.61P/S2.883.49EV/EBITDA36.0518.38P/B1.223.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Jan 7next report, after the close
EPS estimate$0.08
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate